Not all individuals with CLL demand therapy. Irrespective of all new advances, the iwCLL nonetheless recommends watchful observation for individuals with asymptomatic condition.86 This suggestion relies on at the least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (F